AB 1616 directs the California Department of Veterans Affairs to commission research into nonnarcotic treatments for post‑traumatic stress disorder (PTSD), using a department program that funds a study and explicitly calls out hyperbaric oxygen therapy (HBOT) as an example. The measure is a focused, short‑term effort: it creates authority for funding research and requires the department to summarize the study's findings and recommendations for the Legislature.
This bill matters because it tasks a state veterans agency — rather than a health care payer or federal research body — with seeding evidence about alternative PTSD therapies. For policy and compliance professionals, the practical takeaway is that AB 1616 could generate California‑specific clinical evidence that influences coverage, procurement, and clinical practice decisions, but it does so through a narrowly scoped, one‑time study rather than by changing benefit rules directly.
At a Glance
What It Does
The bill requires the Department of Veterans Affairs to establish a program to fund a study of nonnarcotic PTSD treatments and to summarize the study's findings and recommendations for the Legislature. The measure specifically lists hyperbaric oxygen therapy as an example of a treatment to be considered and sets the program as temporary.
Who It Affects
Directly affected parties include the California Department of Veterans Affairs (which must design and oversee the program), researchers and academic medical centers positioned to receive study funding, and veterans with PTSD who are the subject population for the research. Indirectly, state health policymakers, insurers, and providers could use the resulting evidence to reassess coverage and clinical pathways.
Why It Matters
AB 1616 creates a state‑level funding vehicle to produce evidence on alternatives to narcotic treatments for PTSD — a topic with clinical, procurement, and benefits implications. Even though the bill does not mandate coverage changes, its results could prompt legislative or administrative follow‑up and affect how stakeholders evaluate nonnarcotic therapies for veterans.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill adds a single, temporary authority for the Department of Veterans Affairs to fund research into nonnarcotic treatments for PTSD. Rather than prescribing a study design, AB 1616 gives the department the job of establishing a program that will distribute money to a study or studies examining alternative therapies; it names hyperbaric oxygen therapy as an explicit example of the kinds of interventions the department may examine.
Because the authority to spend depends on an appropriation, the department will need a legislative funding allocation before it can act. Once funded, the department will have to translate the statutory instruction into operational steps: define study goals and endpoints, allocate grants or contracts, select research partners (universities, hospitals, or private investigators), and set oversight and reporting conditions.
The statute does not specify those procedural details, so the department will have discretion over procurement method, allowable study designs (clinical trial vs. observational study), outcome measures, sample sizes, or timelines — all of which materially affect how useful the resulting evidence will be.The bill requires the department to collect the study results and produce a written summary with recommendations for the Legislature. The reporting obligation follows state reporting rules, meaning the department must format and submit the document per Government Code standards.
AB 1616 does not itself change benefit entitlements, require the department to provide any treatment to veterans, or alter Medi‑Cal or federal VA policies — it creates a mechanism to build data that others may use to make those decisions. The program is explicitly temporary, which limits its scope but also raises questions about follow‑up studies and long‑term monitoring of any therapies the study identifies as promising.
The Five Things You Need to Know
The department may only implement the program if the Legislature provides an appropriation — the bill authorizes funding but does not itself allocate money.
The statute directs the department to fund a study of nonnarcotic PTSD treatments and explicitly mentions hyperbaric oxygen therapy as a treatment to be considered.
The department must submit a written report summarizing the study's findings and recommendations to the Legislature; the report must follow the state's standard submission rules.
The authority created by the bill is temporary: the statute contains a sunset repealer that terminates the provision after the one‑time study period.
AB 1616 authorizes study funding only; it does not require the department or insurers to adopt, cover, or deliver any specific PTSD treatment based on the study's results.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Program to fund a study of nonnarcotic PTSD treatments
This subsection instructs the Department of Veterans Affairs to establish a program that will fund a study into nonnarcotic therapies for PTSD, naming hyperbaric oxygen therapy as an example. Practically, that gives the department authority to design a funding vehicle — likely grants or contracts — but leaves key design choices (eligibility, selection criteria, award size, and study design) to the department and any implementing procurement rules.
Reporting requirements to the Legislature
The department must prepare a report that summarizes the study's findings and recommendations and submit it to the Legislature. The report must be transmitted in compliance with state reporting procedures (referenced via Government Code submission rules), which affects format and publication but does not constrain the substantive content beyond the bill's instruction to summarize findings and recommendations.
Sunset and limited term
This subsection sets a repeal date for the new authority, making the program time‑limited. The sunset means the statute creates a one‑off or short‑run mechanism rather than an ongoing research program; it places a premium on completing a usable study and report within the available window and raises follow‑up considerations should further research be warranted.
This bill is one of many.
Codify tracks hundreds of bills on Veterans across all five countries.
Explore Veterans in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- California veterans with PTSD — they stand to gain clearer evidence about nonnarcotic therapies that could expand treatment options if the research supports effectiveness.
- Academic medical centers and clinical researchers — the bill creates a new state funding source and grant opportunity for teams with expertise in PTSD and alternative therapies.
- State policymakers and legislative staff — they will receive California‑specific findings and recommendations that can inform future laws, budget decisions, or administrative rule‑making.
Who Bears the Cost
- California state budget taxpayers — the program requires a legislative appropriation, which competes with other budget priorities and carries an explicit fiscal cost if funded.
- California Department of Veterans Affairs — the department must allocate staff time and administrative resources to design, oversee, and report on the program; without earmarked administrative funding, this could divert resources from ongoing services.
- Research institutions and healthcare providers — participating studies will face compliance, IRB, and reporting requirements and may need to provide matching resources or patient recruitment support, which entails time and expense.
Key Issues
The Core Tension
The central dilemma is speed versus rigor: lawmakers want faster answers and alternatives to narcotic treatments for veterans, but producing reliable, policy‑actionable evidence requires careful, often slow study design, adequate sample sizes, and coordination with existing research — trade‑offs that the bill's narrow, temporary funding authority does not resolve.
The bill is narrowly framed as a funding authority for a study, but the legislative value of that study depends entirely on design quality. The statute does not mandate randomized controlled trials, specify outcome measures, define the target population, or require independent peer review — all elements that determine whether the results will be convincing to clinicians, payers, and federal agencies.
If the department opts for small or observational studies, the findings may be insufficient to change clinical guidelines or coverage decisions.
Coordination and duplication are also potential issues. Federal agencies and the U.S. Department of Veterans Affairs already fund PTSD research; the state study could complement or duplicate that work.
The bill provides no direction on coordinating with federal VA research, existing clinical trials, or national registries. The sunset clause compresses the timeline for meaningful follow‑up and replication, and the appropriation trigger means the program may never launch, leaving the statute as an unfunded mandate in practice.
Finally, naming hyperbaric oxygen therapy raises political and clinical stakes: HBOT has advocates and skeptics, and poorly designed state‑funded research could be used selectively by both sides to justify premature policy changes.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.